Michael D Casey - Net Worth and Insider Trading

Michael D Casey Net Worth

The estimated net worth of Michael D Casey is at least $15 Million dollars as of 2024-11-13. Michael D Casey is the Director of Celgene Corp and owns about 116,804 shares of Celgene Corp (CELG) stock worth over $13 Million. Michael D Casey is also the Director of Abaxis Inc and owns about 23,700 shares of Abaxis Inc (ABAX) stock worth over $2 Million. Details can be seen in Michael D Casey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael D Casey has not made any transactions after 2018-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Michael D Casey

Michael D Casey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael D Casey owns 4 companies in total, including Abaxis Inc (ABAX) , Durect Corp (DRRX) , and Sarepta Therapeutics Inc (SRPT) among others .

Click here to see the complete history of Michael D Casey’s form 4 insider trades.

Insider Ownership Summary of Michael D Casey

Ticker	Comapny	Transaction Date	Type of Owner
ABAX	Abaxis Inc	2018-07-31	director
DRRX	Durect Corp	2004-03-19	director
SRPT	Sarepta Therapeutics Inc	2006-05-24	director
		2007-01-01	director

Michael D Casey Latest Holdings Summary

Michael D Casey currently owns a total of 2 stocks. Among these stocks, Michael D Casey owns 116,804 shares of Celgene Corp (CELG) as of June 7, 2018, with a value of $13 Million and a weighting of 86.54%. Michael D Casey also owns 23,700 shares of Abaxis Inc (ABAX) as of March 8, 2018, with a value of $2 Million and a weighting of 13.46%.

Latest Holdings of Michael D Casey

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CELG	Celgene Corp	2018-06-07	116,804	108.24	12,642,865
ABAX	Abaxis Inc	2018-03-08	23,700	83.00	1,967,100

Holding Weightings of Michael D Casey

Michael D Casey Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael D Casey has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 13,000 shares on June 7, 2018, which brought Michael D Casey around $1 Million.

According to the SEC Form 4 filings, Michael D Casey has made a total of 0 transactions in Abaxis Inc (ABAX) over the past 5 years. The most-recent trade in Abaxis Inc is the sale of 5,000 shares on March 8, 2018, which brought Michael D Casey around $355,350.

Insider Trading History of Michael D Casey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael D Casey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael D Casey Ownership Network

Ownership Network List of Michael D Casey

No Data

Ownership Network Relation of Michael D Casey

Michael D Casey Owned Company Details

What does Abaxis Inc do?

Who are the key executives at Abaxis Inc?

Michael D Casey is the director of Abaxis Inc. Other key executives at Abaxis Inc include CFO and VP of Finance Taylor Dean Ross Jr , and director & CEO & Board Chairman Clinton Severson .

Abaxis Inc (ABAX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Abaxis Inc (ABAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Abaxis Inc (ABAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Abaxis Inc (ABAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Abaxis Inc Insider Transactions

No Available Data

What does Durect Corp do?

Who are the key executives at Durect Corp?

Michael D Casey is the director of Durect Corp. Other key executives at Durect Corp include Chief Financial Officer Timothy M. Papp , Chief Medical Officer Norman Sussman , and 10 percent owner Bleichroeder Lp .

Durect Corp (DRRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Durect Corp (DRRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Durect Corp (DRRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Durect Corp (DRRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Durect Corp Insider Transactions

No Available Data

What does Sarepta Therapeutics Inc do?

Who are the key executives at Sarepta Therapeutics Inc?

Michael D Casey is the director of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, Michael D Casey made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf .

In summary, during the past 3 months, insiders sold 5,985 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 37,038 shares, with a net purchase of 31,053 shares. During the past 18 months, 99,430 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 81,365 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sarepta Therapeutics Inc Insider Transactions

No Available Data

What does Capstone Holding Corp do?

Who are the key executives at Capstone Holding Corp?

Michael D Casey is the director of Capstone Holding Corp. Other key executives at Capstone Holding Corp include other: See Remarks Alimco Financial Corp , 10 percent owner Neil S Subin , and 10 percent owner Miller Lloyd I Iii .

Capstone Holding Corp (CAPS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Capstone Holding Corp (CAPS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Capstone Holding Corp (CAPS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Capstone Holding Corp (CAPS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Capstone Holding Corp Insider Transactions

No Available Data

Michael D Casey Mailing Address

Above is the net worth, insider trading, and ownership report for Michael D Casey. You might contact Michael D Casey via mailing address: Allos Therapeutics, Inc., 11080 Circlepoint Road, Suite 200, Westminster Co 80020.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.